Doxycycline for Emphysema in People Living With HIV (The DEPTH Trial)

05/16/2022
Participation Deadline: 02/01/2027
Apply Now

Description

This study is a phase II, multicenter, randomized, double-blinded, placebo-controlled clinical trial in approximately 250 people living with HIV who have emphysema.

Eligible participants will be randomized in a 1:1 fashion to doxycycline or placebo. Participants will receive 100 mg doxycycline orally or matched placebo twice a day for 72 weeks.